These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 8473753)

  • 21. Specific immuno capturing of the staphylococcal superantigen toxic-shock syndrome toxin-1 in plasma.
    Adams H; Brummelhuis W; Maassen B; van Egmond N; El Khattabi M; Detmers F; Hermans P; Braam B; Stam J; Verrips T
    Biotechnol Bioeng; 2009 Sep; 104(1):143-51. PubMed ID: 19475676
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toxic shock syndrome toxin-1 accelerated collagen-induced arthritis in mice.
    Kageyama Y; Koide Y; Nagata T; Uchijima M; Yoshida A; Arai T; Miura T; Miyamoto C; Nagano A
    J Autoimmun; 2001 Mar; 16(2):125-31. PubMed ID: 11247638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modeling of receptor mimics that inhibit superantigen pathogenesis.
    Möllhoff M; Zanden HB; Shiflett PR; Gupta G
    J Mol Recognit; 2005; 18(1):73-83. PubMed ID: 15459942
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Defense against biologic warfare with superantigen toxins.
    Kaempfer R; Arad G; Levy R; Hillman D
    Isr Med Assoc J; 2002 Jul; 4(7):520-3. PubMed ID: 12120463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Stimulation of the immune system by microbial "superantigens"].
    Fleischer B
    Immun Infekt; 1991 Feb; 19(1):8-11. PubMed ID: 2060968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human peripheral gammadelta T cells potentiate the early proinflammatory cytokine response to staphylococcal toxic shock syndrome toxin-1.
    Kalyan S; Chow AW
    J Infect Dis; 2004 May; 189(10):1892-6. PubMed ID: 15122526
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of circulating superantigens in an intensive care unit population.
    Azuma K; Koike K; Kobayashi T; Mochizuki T; Mashiko K; Yamamoto Y
    Int J Infect Dis; 2004 Sep; 8(5):292-8. PubMed ID: 15325598
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of site-specific monoclonal antibodies directed to toxic shock syndrome toxin-1 in experimental Staphylococcus aureus arthritis.
    Verdrengh M; Kum W; Chow A; Tarkowski A
    Clin Exp Immunol; 1999 Nov; 118(2):268-70. PubMed ID: 10540189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of total body irradiation and cyclosporin a on the lethality of toxic shock syndrome toxin-1 in a rabbit model of toxic shock syndrome.
    Dinges MM; Gregerson DS; Tripp TJ; McCormick JK; Schlievert PM
    J Infect Dis; 2003 Oct; 188(8):1142-5. PubMed ID: 14551884
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Superantigen antagonist blocks Th1 cytokine gene induction and lethal shock.
    Arad G; Hillman D; Levy R; Kaempfer R
    J Leukoc Biol; 2001 Jun; 69(6):921-7. PubMed ID: 11404377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of T cell receptors engineered for high affinity against toxic shock syndrome toxin-1.
    Buonpane RA; Moza B; Sundberg EJ; Kranz DM
    J Mol Biol; 2005 Oct; 353(2):308-21. PubMed ID: 16171815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Superantigens associated with staphylococcal and streptococcal toxic shock syndrome are potent inducers of tumor necrosis factor-beta synthesis.
    Hackett SP; Stevens DL
    J Infect Dis; 1993 Jul; 168(1):232-5. PubMed ID: 8515117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of staphylococcal enterotoxin A-induced superantigenic and lethal activities by a monoclonal antibody to toxic shock syndrome toxin-1.
    Kum WW; Chow AW
    J Infect Dis; 2001 Jun; 183(12):1739-48. PubMed ID: 11372026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential roles of interleukin-18 (IL-18) and IL12 for induction of gamma interferon by staphylococcal cell wall components and superantigens.
    Stuyt RJ; Netea MG; Kim SH; Novick D; Rubinstein M; Kullberg BJ; Van der Meer JW; Dinarello CA
    Infect Immun; 2001 Aug; 69(8):5025-30. PubMed ID: 11447182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Superantigens and pseudosuperantigens of gram-positive cocci.
    Fleischer B; Gerlach D; Fuhrmann A; Schmidt KH
    Med Microbiol Immunol; 1995 May; 184(1):1-8. PubMed ID: 8538573
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunization with glutathione S-transferase and mutant toxic shock syndrome toxin 1 fusion protein protects against Staphylococcus aureus infection.
    Cui JC; Hu DL; Lin YC; Qian AD; Nakane A
    FEMS Immunol Med Microbiol; 2005 Jul; 45(1):45-51. PubMed ID: 15985222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of recombinant SEA-TSST fusion toxoid for protection against superantigen induced toxicity in mouse model.
    Reddy PN; Paul S; Sripathy MH; Batra HV
    Toxicon; 2015 Sep; 103():106-13. PubMed ID: 26091873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The effect of Staphylococcus aureus toxic shock exotoxin on whole blood cell chemiluminescence in vitro and in vivo].
    Antipov AIu; Shepelev AP; Poliakov VM
    Vopr Med Khim; 1995; 41(2):40-2. PubMed ID: 7793095
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential arthritogenicity of Staphylococcus aureus strains isolated from biological samples.
    Colavite-Machado PM; Ishikawa LL; França TG; Zorzella-Pezavento SF; da Rosa LC; Chiuso-Minicucci F; da Cunha Mde L; Garlet GP; Sartori A
    BMC Infect Dis; 2013 Aug; 13():400. PubMed ID: 23988021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pyrogenic toxins of Staphylococcus aureus in sudden unexpected nocturnal deaths in adults and older children: factors influencing the control of inflammatory responses to toxic shock syndrome toxins.
    Al Madani O; Gordon AE; Weir DM; Raza MW; Busuttil A; Blackwell C
    FEMS Immunol Med Microbiol; 1999 Aug; 25(1-2):207-19. PubMed ID: 10443510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.